Risk assessment of carcinogens and the threshold range, Part 1;Die risikobewertung von kanzerogenen und die wirkungsschwelle, teil I

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 49, Issue 7, 2006, Pages 665-674

  Neumann, H G ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

CHEMICALLY INDUCED DISORDER; DIFFERENTIAL THRESHOLD; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; NEOPLASM; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

CARCINOGENS; DATA INTERPRETATION, STATISTICAL; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 33746513193     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-006-1287-7     Document Type: Review

References (50)

1. Druckrey H (1943) Quantitative Grundlagen der Krebserzeugung. Klin Wochenschrift 22: 532-534
2. Marquardt H, Schäfer S (Hrsg.) Lehrbuch der Toxikologie, 2. Aufl. 2004, Wissenschaftliche Verlagsgesellschaft, Stuttgart
3. Alberts B, Bray D, Lewis J et al. (Hrsg) The cell, molecular Biology, 2nd edn. Garland Publ. Inc., New York London
4. Uehleke H (1983)Thresholds in acute and long term animal studies. In: Possible mechanisms of thresholds for carcinogens and other toxic substances. J Am Coll Toxicol 2(3): 245-268
5. ACGIH (American Conference of Governmental Hygenist:TLVs and BEIs) (2004) Threshold Limit Values and Biological Exposure Indices
6. Mastromatteo E (1981) On the concept of threshold. Amer Ind Hyg Assoc J 42: 763-770
7. TLVs and BEIs, Threshold Limit Values and Biological Exposure Indices (2004) ACGIH, Cincinnaty, USA
8. MAK- und BAT-Werte-Liste (2004) Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, DFG. Wiley, Weinheim
9. Aldridge WN (1995) Defining thresholds in occupational and environmental toxicity. Toxicol Lett 77: 109-118
10. Kisch-Volders M, Aardema M, Elhajouji A (2000) Concepts of threshold in mutagenesis and carcinogenesis. Mutat Res 464: 3-11
11. Seiler JP (1977) Apparent and real thresholds. In: Scott D, Bridges BA, Sobels FH (eds) Progress in genetic toxicology. Elsevier/North Holland Biomedical Press, pp 233-2238
12. EU-Bericht v. 26.10.2000. First Report on the Harmonisation of Risk Assessment Procedures. 2. Appendices
13. Risiko-Kommission (2003) Ad-hoc-Kommission "Neuordnung der Verfahren und Strukturen zur Risikobewertung und Standardsetzung im gesundheitlichen Umweltschutz in der Bundesrepublik Deutschland". Abschlussbericht 2003
14. Reichel FX, Schwenk M (Hrsg) (2004) Regulatorische Toxikologie. Springer, Berlin Heidelberg
15. Teutschlaender O, Schuster H (1926) Zur Histopathogenese des experimentellen Teerkrebses. Z Krebsforsch 23: 184;
16. Teutschlaender O (1934) Reizkrebse, ihre Entstehung und Verhütung mit Berücksichtigung der beruflichen Krebsbildungen. Wiss Woche, Georg Thieme, Frankfurt, zitiert in [16]
17. Schmähl D (1979) Problems of dose-response studies in chemical carcinogenesis with special reference to N-Nitroso compounds. CRC Critical Reviews in Toxicology, pp 257-281
18. Druckrey H, Schmähl D, Dischler W, Schildbach A (1962) Quantitative Analyse der experimentellen Krebserzeugung. Naturw 49: 217-228
19. Druckrey H (1959) Pharmacological approach to carcinogenesis. Ciba Foundation Symposium on Carcinogenesis, Mechanisms of Action, Wolstenholm GEW, O'Connor M (Hrsg) L&A Churchill Ltd. Gloucester, GB, pp 110-130
20. Pong RS, Wogan GN (1970) Time course and dose-response characteristics of aflatoxin B1 Effects on rat liver DNA polymerase and ultrastructure. Cancer Res 30: 294-304
21. Miller JA, Miller EC (1971) Chemical carcinogenesis: Mechanisms and approaches to its control. Guest Editorial. J Natl Cancer Inst 47: V-XIV
22. Dinman BD (1972) Non-Concept of no-threshold: chemicals in the environment. Science 175: 495-497
23. Henschler D (1973) Veränderungen der Umwelt - Toxikologische Probleme. Angew Chem 85: 317-326
24. Henschler D (1973) Toxicological problems relating to changes in the environment. Angew Chem Int Ed Engl 12: 274-282
25. Henschler D (1974) New approaches to a definition of threshold values for irreversible effects. Arch Toxicol 32: 63-67
26. Claus G (1974) Environmental carcinogenesis; is there a threshold of exposure. Clin Toxicol 7: 497-508;
27. Claus G, Krisko I, Bolander K (1974) Chemical carcinogens in the environment and the human diet: can a threshold be established. Fd Cosmet Toxicol 12: 737-746
28. Bridges BA, Stamper JG (1975) Hypothetical dose-response curves for chronic exposures to mutagens or carcinogens subject to simple enzymatic detoxification in the mammalian body. Mutat Res 33: 87-91
29. Stockinger HE (1972) Concepts of thresholds in standards setting. Arch Environ Hlth 25: 153-157
30. Burnet FM (1976) Mutation, somalische Mutation und Krankheit beim Menschen. Naturw Rdsch 29: 305-311
31. Koelle GB (1977) The zero-tolerance concept. Perspec Biol Med 20: 507-509
32. Mantel N, Schneiderman MA (1975) Estimating "safe" levels, a hazardous undertaking. Cancer Res 35: 1379-1386
33. Roach SA, Rappaport SM (1990) But they are not thresholds: a critical analysis of the documentation of threshold limit values. Am J Indust Med 17: 727-753
34. Cox C (1987) Threshold dose-response models in toxicology. Biometrics 43: 511-523
35. Neumann HG (1980) Biochemical effects and early lesions in regard to dose-response-studies. Oncology 37: 255-258
36. Schneiderman MA, Brown CC (1978) Estimating cancer risk to a population. Environ Health Perspect 22: 115-124
37. HG Neumann (1974) Ultimate electrophillic carcinogens and cellular nucleophilic reactants. Arch Toxicol 32:27-38
38. Rjosk HK, Neumann HG (1971) Zur Bedeutung chemisch-biologischer Wechselwirkungen für die toxische und Krebs erzeugende Wirkung aromatischer Amine. II. Z Krebsforsch 75: 209-220
39. Neumann HG, Gaugler BJM, Taupp W (1978) The metabolic activation of trans-4-dimethylaminostilben after oral administration of doses ranging from 0.025 to 250 μmol/kg. Proc First Intern Congress Toxicol. Academic Press, pp 177-189
40. Neumann HG, Baur H, Wirsing R (1980) Dose-response relationship in the primary lesion of strong electrophilic carcinogens. In: Quantitative aspects of risk assessment in chemical carcinogenesis. Arch Toxicol Suppl 3: 69-77, Diskussion pp 145-147
41. Ehrenberg L, Moustacchi E, Osterman-Golkar S (1983) Dosimetry of genotoxic agents and dose reponse relationsships. Mutat Res 123: 121-182
42. Neumann HG (1973) Ultimale elektrophile Carcinogene und nukleophile Reaktanten der Zelle. Vortrag: 14. Frühjahrstagung der DGPT, 18.-21.3. Mainz
43. Neumann HG (1979) Pharmacokinetic parameters influencing tissue specificity in chemical carcinogenesis. Arch Toxicol Suppl 2: 229-238
44. Scott Appleton B, Goetchius MP, Campbell TC (1982) Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures. Cancer Res 42: 3659-3662
45. Diaz Gomez MI, Swann PF, Magee P (1977) The absorption and metabolism in rats of small oral doses of dimethylnitrosoamine. Biochem J 164: 497-500
46. Montesano R (1981) Alkylation of DNA and tissue specificity in nitrosamne carcinogenesis. J Supramol Structure Cell Biochem 17: 259-273
47. Dunn BP (1983) Wide range linear dose-response curve for DNA binding of orally administered Benzo(a)pyrene in mice. Cancer Res 43: 2654-2658
48. Zerban H, Preussmann R, Bannasch P (1988) Dose-time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine. Carcinogenesis 9: 607-610
49. Lutz WK (1987) Quantitative evaluation of DNA-Bindung data in vivo for low-dose extrapolations. Arch Toxicol Suppl 11: 66-74
50. Lutz WK, Gaylor D (1996) Significance of DNA adducts at low dose: shortening the time to spontaneous tumor occurrence. Regul Tocicol Pharmacol 23: 29-34